Details

NameSymbolSector
ORCHID PHARMA LIMITEDORCHPHARMAPharmaceuticals
Open
780.8
High
780.8
Low
740.5
Close
748.25
Volume
48764
Exchange
nse
Time
14/08

Outlook

Score:  

2.75

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Orchid Pharma is  
Opening Marubozu
Estimated Stoploss of Orchid Pharma is ₹  
780.8
Orchid Pharma has a  
Bearishℹ
 pattern. 
Formation of  
Opening Marubozu
 candle pattern indicates Orchid Pharma has chances of  
Continuationℹ
 of the current trend. 

Trend

Orchid Pharma is in  
Sideways trendℹ
. 
Price of Orchid Pharma is  
Upℹ
 by  

1.94

%. 
Target
Buy @ 

660.41

Sell @ 

786.95

Volume

The trade volumes of Orchid Pharma have become  
Deficientℹ
Though the volume trend for Orchid Pharma appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Orchid Pharma is  

Down

 by  

65.45

% 

Valuation

The current market price of Orchid Pharma is  
Undervaluedℹ

Financials

Balance
The balance sheet of Orchid Pharma is:  

Balanced

Cashflow
Orchid Pharma has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 17cr

. It is  
Upℹ
 by  

194.44

%. 

(*Mar 2025)

27.14% i.e. ₹ 19cr earned in operatingℹ
37.14% i.e. ₹ 26cr spent in investingℹ
35.71% i.e. ₹ 25cr earned in financingℹ
0% in otherℹ
Orchid Pharma has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 18cr

. It is  
Downℹ
 by  

200

%. 

(*Mar 2024)

20.7% i.e. ₹ 125cr earned in operatingℹ
51.66% i.e. ₹ 312cr spent in investingℹ
27.65% i.e. ₹ 167cr earned in financingℹ
0% in otherℹ
Income
The income of Orchid Pharma is  

₹ 184cr

 and  

Profit

 is :  

₹ 13cr

(*Jun 2025)

Orchid Pharma Profit is down by:  

31.58

% and Income is Down by:  

23.65

% 

(*Jun 2025)

The income of Orchid Pharma is  

₹ 241cr

 and  

Profit

 is :  

₹ 19cr

(*Mar 2025)

Orchid Pharma Profit is down by:  

13.64

% and Income is Up by:  

7.11

% 

(*Mar 2025)

The income of Orchid Pharma is  

₹ 225cr

 and  

Profit

 is :  

₹ 22cr

(*Dec 2024)

Orchid Pharma Profit is down by:  

12

% and Income is Down by:  

2.17

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.